LLY

3 Stocks Primed to Reach Trillion-Dollar Valuation

By Faizan Farooque, InvestorPlace Contributor
Explore the elite world of trillion-dollar stocks and uncover insights on the companies dominating the market with unparalleled valuations.

My Top 3 Stock Candidates to Replace Tesla in the Magnificent 7

By Will Ashworth, InvestorPlace Contributor
The Magnificent 7 stocks are mostly doing well in 2024. It would still be a good bet if not for Elon Musk’s company.

Meet the Next Trillion-Dollar Companies: Our Top 7 Picks

By Jeremy Flint, InvestorPlace Contributor
These future trillion-dollar stocks are on their way to mythic valuation, supported by strong underlying fundamentals and prospects.

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

By Alex Sirois, InvestorPlace Contributor
Obesity drug sales boomed in 2023 and will continue in 2024 making these weight loss stocks attratcive considerations for pharma investors.

3 Stocks to Sell Immediately Before the Bubble Bursts: February 2024

By Ian Bezek, InvestorPlace Contributor
These three high-flying stocks to sell are set for a major decline when the stock market bubble pops. It's time to dump them.

Move Over, Tesla: 5 Stocks That Could Take Its Place in the Magnificent Seven

By Thomas Yeung, CFA, InvestorPlace Markets Analyst
Tesla is losing its luster as a member of the Magnificent Seven in 2024. Consider one of these other high fliers to take its place.

Eli Lilly, Novo Nordisk Could Be First Trillion-Dollar Drug Stocks

By Paul R. La Monica, InvestorPlace Contributor
Thanks to weight loss and obesity drugs, Eli Lilly and Novo Nordisk could become the first trillion-dollar stocks in the pharma industry.

3 High-Octane Growth Stocks Not Slowing Down Any Time Soon

By Chris MacDonald, InvestorPlace Contributor
These high-octane growth stocks provide the kind of upside long-term investors should want from higher-risk bets.

NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?

By Rich Duprey, InvestorPlace Contributor
The relaunch of Wegovy last year caused a mad dash by weight loss stocks to compete for market leadership in anti-obesity drugs.

3 Pharma Stocks to Sell in February Before They Crash and Burn

By Ian Bezek, InvestorPlace Contributor
The good times are coming to an end for these overpriced pharma stocks to sell this month before they crash and burn.

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024

By Alex Sirois, InvestorPlace Contributor
Biotech stocks are warming up in January and look to continue upward in 2024 as the economy improves.

3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024

By Chris Markoch, InvestorPlace Contributor
There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains

5 Mega-Cap Stocks Ready to Make the Magnificent 7 a Dynamic Dozen

By Paul R. La Monica, InvestorPlace Contributor
With mega-cap stocks setting new highs, here are five new names that could take the Magnificent 7 to a Dynamic Dozen.

Portfolio Protection: 7 Risky Stocks to Drop Right Now

By Thomas Niel, InvestorPlace Contributor
Ahead of further or unforeseen challenges, if you own any of these seven risky stocks, now's the time to bail.

Q1’s Rising Stars: 3 Dividend Stocks with Massive Upside

By Chris Markoch, InvestorPlace Contributor
Even if risk-on sentiment returns to market, there are still several catalysts nudging investors to look for dividend stocks to buy

3 Stocks to Make You the Millionaire Next Door: 2024 Edition

By Joel Baglole, InvestorPlace Contributor
Investors wanting to maximize the gains in their portfolio should take a position in one of these leading companies.

2024’s Power Players: 7 Stocks Racing to a Trillion Valuation

By Thomas Niel, InvestorPlace Contributor
Whether in 2024, or in the years ahead, each of these seven stocks could become the next trillion dollar companies.

3 Ken Griffin Stocks to Invest Like Citadel

By Alex Sirois, InvestorPlace Contributor
Invest like Citadel founder and billionaire Ken Griffin with these stocks that have strong potential heading into 2024.

Looking Beyond Tech: 7 High-Growth Stocks for Substantial Returns

By Muslim Farooque, InvestorPlace Contributor
Place your bets on these high-growth stocks beyond tech in 2024, for a more balanced and innovative investment portfolio.
Load More